StemCellPatents.com is dedicated to maintaining the utmost quality of content for its readers. Accordingly, an independent international advisory board of professionals guides strategic direction, as well as provides ideas on content of this website. Current advisory board members include:
Chief Executive Officer of MBVax Corporation, is a seasoned technology executive. He is the former president of CRS Robotics Corporation, a manufacturer of laboratory robotic systems, and former president and chief executive officer of Tm Bioscience Corporation, a manufacturer of biochips and developer of DNA technologies. Mr. MacAdam is the author of Spontaneous Regression: Cancer and the Immune System. In his current company, Mr MacAdam is developing a therapeutic vaccine for cancer.
A Professor of Medicine at that Hunan Medical University in Changsha, China, Dr Zhong is well published in the area of immunology, cell therapy, and surgery. His contributions to StemCellPatents.com is primarily in the area of translational research and conceptualization of ways to accelerate integration of stem cell therapeutics with current surgical practices. Dr Zhong is a urological surgeon in China with North American experience..
Dr. Vladimir Bogin is a Board Certified Internist with a practice in Longview Washington and positions at various academic institutions in the US and Russia. He is a principle of Cromos Pharma Services a contract research organization with performs clinical trials for novel therapeutics. Dr Bogin is head of the Charitable Foundation of the Russian American Medical Association, an organization that provides American medical care for conditions untreatable in Russia.